Navigation Links
PhRMA Statement on Department of Homeland Security Efforts to Crack Down on Counterfeiting Crimes
Date:12/15/2010

WASHINGTON, Dec. 15, 2010 /PRNewswire-USNewswire/ -- Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO John Castellani released the following statement regarding the Department of Homeland Security stepping up efforts to combat counterfeit drugs:

"The Department of Homeland Security's (DHS) decision to step up efforts to eliminate counterfeit medicines should not only be applauded but should also serve as a warning sign to criminals selling fake and harmful counterfeit pharmaceuticals to unsuspecting consumers.

"No country is immune to the worldwide counterfeit medicine threat. A growing web of criminal networks around the globe are selling dangerous counterfeit drugs to innocent victims – people who might think they're getting a good deal but in reality are receiving medicines that are fake, substandard and in some cases lethal. Make no mistake: criminals are not only targeting 'lifestyle' drugs but also vital medicines that treat cancer, diabetes, malaria and high blood pressure.

"The most common mechanism for counterfeit drugs to enter the U.S. drug supply is through purchases made on illegal online pharmacy sites that are operated by criminals in other countries with known counterfeiting problems. Cracking down on these illegal sites can help protect patient safety and help ensure that the closed U.S. drug supply system is not compromised.

"In most cases, criminals caught selling counterfeit medicines in the U.S. face lighter jail sentences and penalties than criminals selling illicit drugs such as heroin. For this reason, PhRMA will continue to advocate for stricter sentencing guidelines for counterfeiters – the average jail time for a counterfeiting crime is 3 years but we believe that 20 years is a better fit for such a potentially deadly crime.

"In the meantime, America's biopharmaceutical research companies will continue to work with key government agencies – such as DHS an
'/>"/>

SOURCE Pharmaceutical Research and Manufacturers of America
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. PhRMA CEO John Castellani Responds to Mid-Term Election, Stresses Importance of Innovation to Help Grow Economy
2. PhRMA Statement on Health Care Reform
3. Pfizers Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts
4. PhRMA Honors Patient Advocates Ron and Raychel Bartek
5. Seven New Biopharmaceutical Research Companies Join PhRMAs Mission to Advance Medical Innovation
6. PhRMA Statement Supporting Fair Incentives for Biologics Innovation
7. PhRMA Statement on Senate Finance Committee Vote
8. Lilly Statement Regarding President Obamas Meeting With U.S. Business Leaders
9. AcelRx Pharmaceuticals Files Registration Statement for Proposed Initial Public Offering
10. ERT Files Shelf Registration Statement
11. Ambit Biosciences Files Registration Statement for Proposed Initial Public Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... Sept. 23, 2014 Research and ... "Physician Office Laboratory Markets, 3rd Edition" ... report, Physician Office Laboratory Markets is Kalorama,s complete ... industry. Physician office laboratories are diverse in their ... reimbursable, in-office pregnancy and glucose tests. Some specialty ...
(Date:9/23/2014)... , September 23, 2014 ... has announced the addition of the  "Large ... to their offering.  ,     ... drug delivery market holds significant potential for ... vials and painful needles to the modern-day ...
(Date:9/23/2014)... 2014  SiteOne Therapeutics Inc. today announced the completion ... Sears Capital Management and Biobrit LLC, with additional investors ... $1.5 million financing positions SiteOne to advance its oral ... further develop its technology platform for long-acting local analgesics, ... conjunction with the financing, Lowell Sears (Sears ...
Breaking Medicine Technology:Physician Office Laboratory Markets, 3rd Edition 2Physician Office Laboratory Markets, 3rd Edition 3Large Volume Wearable Injectors - 2nd Edition 2Large Volume Wearable Injectors - 2nd Edition 3Large Volume Wearable Injectors - 2nd Edition 4Large Volume Wearable Injectors - 2nd Edition 5SiteOne Therapeutics Completes $1.5M Initial Round of Equity Financing, Secures $1.4M NIH Grant 2SiteOne Therapeutics Completes $1.5M Initial Round of Equity Financing, Secures $1.4M NIH Grant 3
... New study questions ability of human-animal hybrids to generate ... Cell Technology, Inc. (OTC Pink Sheets: ACTC) and its ... the capacity to extensively reprogram adult human cells. The ... journal Cloning and Stem Cells (Editor-in-Chief: Sir ...
... Inc., the leader in the,development of devices for ... start of enrollment in the REALISM (Real World ... continued access,registry. The MitraClip(R) system is currently being ... option for patients suffering from the,effects of mitral ...
Cached Medicine Technology:Cloned Human Embryos Successfully Reprogrammed Using Human - But Not Animal - Eggs 2Cloned Human Embryos Successfully Reprogrammed Using Human - But Not Animal - Eggs 3Cloned Human Embryos Successfully Reprogrammed Using Human - But Not Animal - Eggs 4Cloned Human Embryos Successfully Reprogrammed Using Human - But Not Animal - Eggs 5First U.S. Patients Enrolled in the REALISM Continued Access Study 2First U.S. Patients Enrolled in the REALISM Continued Access Study 3
(Date:9/23/2014)... Dr. Connie Casad has announced that she will be relocating ... 12200 Park Central Drive, Suite 200, Dallas, Texas 75251 on ... Aesthetics, Optimal Health and Wellness, her gynecology practice and concierge ... said, “The patients’ comfort and satisfaction are our primary goal. ... always feel like their needs are valued and recognized by ...
(Date:9/23/2014)... rapidly developing, bringing with its advances promises of ... and treatment interventions. Genetic tests are already ... and hepatitis c virus (HPC), and emerging research ... screen for an individual,s susceptibility to addiction to ... , While there appear to be many benefits ...
(Date:9/23/2014)... News) -- Few children who take medication for ... the rates vary six-fold across counties in the ... alone can manage symptoms for many children with ... receive behavioral therapy (psychotherapy), the Rand Corp. researchers ... than 1,500 counties across the United States that ...
(Date:9/23/2014)... Both patients and healthcare professionals believe diagnosis of ... greatly outweighs the potential disadvantages of subsequent radiologic ... according to a new study published in the ... , Diagnostic tests used for cancer screening programs ... for colorectal cancer with CT colonography, abdominal and ...
(Date:9/23/2014)... Boston, MA (PRWEB) September 23, 2014 ... announced that $50,000 investments each were made to ... the top two health ventures with business solutions to ... , SOURCE is a first-of-its-kind collaboration between The ... Investors' Circle that connects entrepreneurs with the investment ...
Breaking Medicine News(10 mins):Health News:Dr. Connie Casad Moving to New Office Location 2Health News:NYU-Mount Sinai Beth Israel study explores drug users' opinions on genetic testing 2Health News:Kids Taking ADHD Drugs Get Little Psychotherapy: Study 2Health News:Patients accept false-positives to achieve diagnostic sensitivity 2Health News:Patients accept false-positives to achieve diagnostic sensitivity 3Health News:$100,000 Awarded to Rimidi Diabetes and TruClinic for Health Business Solutions that Benefit Patients and Providers 2Health News:$100,000 Awarded to Rimidi Diabetes and TruClinic for Health Business Solutions that Benefit Patients and Providers 3Health News:$100,000 Awarded to Rimidi Diabetes and TruClinic for Health Business Solutions that Benefit Patients and Providers 4Health News:$100,000 Awarded to Rimidi Diabetes and TruClinic for Health Business Solutions that Benefit Patients and Providers 5
... talked about by only 20% of patients , , MONDAY, ... rheumatoid arthritis (RA) may be at increased risk for ... says a U.S. study that included 200 RA patients ... Betsy Sleath, of the University of North Carolina at ...
... Feb. 11 CAQH announced today,that the eligibility ... for Information Exchange (CORE) Phase I rules is ... Panel,s (HITSP) first set,of interoperability standards. These standards ... Mike Leavitt late last month., This recognition ...
... Feb. 11 The Employer Support of the ... Alliance to,its list of companies that provide extra-ordinary ... Reserves., National ESGR Executive Director Dr. Gordon ... gathering of the company,s leadership Sunday,in Westlake Village. ...
... Chesapeake Corporation,(NYSE: CSK ), a leading international ... supplier of printed pharmaceutical,leaflets in North America, today ... on Long Island, N.Y., and relocating,from its current ... "Our business has grown substantially since we moved ...
... at Childrens Hospital of Pittsburgh of UPMC have identified a ... the development of a vaccine to prevent and new therapies ... Research led by Jay K. Kolls, MD, chief of the ... identified for the first time the importance of a protein ...
... MINNEAPOLIS, Feb. 11 Uroplasty, Inc. (Amex:,UPI), ... and markets,innovative proprietary products for the treatment ... PC Neuromodulation System, its,proprietary, minimally invasive nerve ... bladder (OAB) symptoms, will be,featured in three ...
Cached Medicine News:Health News:Depression Rarely Discussed With RA Patients 2Health News:CAQH Core Rules Final Component of HITSP Interoperability Standards Formally Recognized By HHS Sec. Leavitt 2Health News:CAQH Core Rules Final Component of HITSP Interoperability Standards Formally Recognized By HHS Sec. Leavitt 3Health News:TriWest Named 'Top-Level' Employer of Guard, Reserve Troops 2Health News:Chesapeake to Expand and Relocate North American Pharmaceutical Packaging Operation 2Health News:Children's Hospital scientists identify possible target for prevention and treatment of pneumonia 2Health News:Studies on Urgent(R) PC to be Presented at the 2008 Society of Urologic Nurses and Associates Annual Symposium 2
0.5mm "K" hook. Rounded knurled handle; shaft angled 11mm from tip; overall length 120mm, in Titanium....
Lightly Curved-Blunt Tips Rounded Blades; 1mm Eye in Blades; 27mm from mid screw to tip. Matte finish; Stainless Steel, overall length 120mm...
... Perfusion Catheter is indicated for ... portion of a coronary artery ... the purpose of improving myocardial ... are also designed to provide ...
... The eSpeed C300 uses its hallmark 50 and ... techniques. New MultiPhase scan protocols and proprietary ... C300s four beam targets and two x-ray detector ... arteries and analyze myocardial perfusion and wall motion. ...
Medicine Products: